RahulKhuranaMD

PubMed

• 15 citations
  Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration.
  Arshad M. Khanani, Vrinda S. Hershberger, Dante J. Pieramici, Rahul N. Khurana, Flavia Brunstein
  American Journal of Ophthalmology. 2021-06-29
• 44 citations
  Private Equity in Ophthalmology and Optometry: Analysis of Acquisitions from 2012 through 2019 in the United States.
  Evan M. Chen, Jacob T. Cox, Tedi Begaj, Grayson W. Armstrong, Rahul N. Khurana
  Ophthalmology. 2020-01-11
• 17 citations
  Evaluation of a Stereoscopic Camera-Based Three-Dimensional Viewing Workstation for Ophthalmic Surgery
  Prashant Bhadri, Adrian P. Rowley, Rahul N. Khurana, Charles Deboer, Ralph Kerns
  American Journal of Ophthalmology. 2007-05-01

Journal Articles

• Anterior Segment Migration of Dexamethasone Implant: Risk Factors, Complications, and Management  
  Rahimy E, Khurana RN, Curr Opin Ophthalmol, 1/1/2017
• Reply  
  Wykoff CC, Le RT, Khurana RN, Wang R, Brown DM, Ou WC, Clark WL, Boyer DS, Am J Ophthalmol, 1/1/2017
• SCORE2 Report 2: Study Design and Baseline Characteristics  
  Scott IU, VanVedhuisen PC, Ip MS, Biodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group, Ophthalmology, 1/1/2017
• Outcomes with As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-month Extension Study  
  Wykoff CC, Le RT, Khurana RN, Wang R, Brown DM, Ou WC, Clark WL, Boyer DS, Am J Ophthalmol, 1/1/2017
• Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)  
  Nguyen QD, Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Thurau S, Abraham A, Wilson L, Yang Y, Sham N; Sirolimus study Assessi..., Ophthalmology, 1/1/2016
• Conversion back to Bevacizumab or Ranibizumab after Aflibercept for recurrent Neovascular Age-Related Macular Degeneration  
  Slean GR, Hemarat K, Khurana RN, Stewart JM, International Journal of Retina and Vitreous, 1/1/2016
• SCORE2 Report 1: Techiques to Optimize Recruitment in Phase III Clinical Trials of Patients with Central Retinal Vein Occlusion  
  Scott IU, VanVedhuisen PC, Ip MS, Biodi BA, Oden NL, Figueroa M; SCORE2 Investigator Group, Am J Ophthalmol, 1/1/2016
• Ranibizumab Treatment for Pigment Epithelial Detachments secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study  
  Sarraf D, London NJ, Khurana RN, Dugel PU, Gune S, Hill L, Tuomi L, Ophthalmology, 1/1/2016
• Increasing Sleep Duration is associated with Geographic Atrophy and Age Related Macular Degeneration  
  Khurana RN, Porco TC, Boldrey EE, Palmer JD, Wieland MR, Retina, 1/1/2016
• Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema  
  Wells JA, Glassman AR, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW;..., JAMA Ophthalmology, 1/1/2016
• Ocular Lyme Disease simulating Acute Posterior Multifocal Placoid Pigment Epitheliolopathy  
  Wang M, Khurana RN, Hopkins JJ, Rao NA, Clin Med Rev Case Rep, 1/1/2015
• Dexamethasone Intravitreal Implant for Pseudophakic Cystoid Macular Edema following Cataract Surgery in Diabetic Patients  
  Khurana RN, Palmer JD, Porco TC, Wieland MR, Ophthalmic Surg Lasers Imaging Retina, 1/1/2015
• Efficacy and Safety of Dexamethasone Intravitreal Implant for Uveitic Cystoid Macular Edema  
  Khurana RN, Porco TC, Retina, 1/1/2015
• Local Therapeutic Options for Uveitic Cystoid Macular Edema  
  Slean GR, Khurana RN, Intl Ophthalmol Clinics, 1/1/2015
• Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post-Hoc Analysis of the RIDE/RISE Clinical Trials  
  Bansal AS, Khurana RN, Wieland MR, Wang PW, Van Everen SA, Tuomi L, Ophthalmology, 1/1/2015
• Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema: Results from RIDE and RISE  
  Bressler NM, Varma R, Suner IJ, Dolan CM, Ward J, Ehrlich JS, Colman S, Turpcu A, RIDE and RISE Research Groups, Ophthalmology, 1/1/2014
• Macular Caldera in North Carolina Macular Dystrophy: Only an Illusion of Posterior Pole Staphyloma  
  Chen C, Khurana RN, Scholl H, Goldberg M, JAMA Ophthalmology, 1/1/2014
• Spontaneous Resolution of Macular Edema in Leber’s Miliary Aneurysms  
  Khurana RN, Ophthalmic Surg Lasers Imaging Retina, 1/1/2013
• Serpiginous Choroiditis secondary to Bartonella Henselae?  
  Khurana RN, JAMA Ophthalmology, 1/1/2013
• Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials: RISE and RIDE  
  Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ; RIDE and RISE Research Group, Ophthalmology, 1/1/2013
• Ranibizumab for Diabetic Macular Edema: results from 2 Phase III randomized trials: RISE and RIDE  
  Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel, S Feiner L, Gibson A, Sy J, Rundle AC, Hopkns JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Study Group, Ophthalmology, 1/1/2012
• Agreement of Time Domain and Spectral Domain Optical Coherence Tomography With Fluorescein Leakage from Choroidal Neovascularization Following Anti-VEGF Therapy  
  Khurana RN, Dupas B, Bressler NM, Ophthalmology, 1/1/2010
• Enterococcus casseliflavus Endolphthalmitis associated with a Horse tail Injury  
  Khurana RN, Leder HA, Nguyen QD, Do DV, Arch Ophthalmol, 1/1/2009
• Diagnostic and Therapeutic Challenges  
  Channa R, Khurana RN, Speicher MA, Shah SM, Do DV, Nguyen QD, Retina, 1/1/2009
• Anti-VEGF Agents for Diabetic Macular Edema  
  Khurana RN, Do DV, Nguyen QD, Intl Ophthalmol Clinics, 1/1/2009
• Join now to see all

Books/Book Chapters

• Review Questions in Ophthalmology 
  Chapter: Retina and Vitreous 
  Page 465.0 - 533.0Bansal AS, Chang LK, Khurana RNEditors: KC Chern and MA Saidel.Wolters Kluwer Health, Philadelphia, PAEdition 3rd,2015

Abstracts/Posters

• Suprachoroidal Triamcinolone Acetonide in Combination With Intravitreal Aflibercept in Patients With Macular Edema Following Retinal Vein Occlusion: Results of the TAN...
  Khurana R, RETICON 2017: The Retina Congress with Live Surgery, Chennai, India, 1/1/2017
• Intravitreal Aflibercept for Previously Treated Macular Edema associated with Central Retinal Vein Occlusions: Two Year Results from the NEWTON Study
  Khurana R, RETICON 2017: The Retina Congress with Live Surgery, Chennai, India, 1/1/2017
• Dexamethasone Implant Anterior Chamber Migration: The Importance of the “Clinical Laboratory”
  Khurana R, RETICON 2017: The Retina Congress with Live Surgery, Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, 2016; Chennai, India, , 1/1/2017
• Use of a Smart Device Mobile App for Monitoring Visual Acuity and Metamorphopsia in patients with Diabetic Retinopathy or Age-Related Macular Degeneration
  Singerman L, Khurana R, Khanani A, Hong C, Ivanhoe RJ, Holcomb R, Association for Research in Vision and Ophthalmology 2016 Annual Meeting, 1/1/2017
• Prophylactic Ranibizumab for Exudative age-related macular deneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinica...
  Lalezary M, Lin S, Chan C, Bansal A, Khurana R, Wieland M, Chang L, Palmer J, Abraham P, Elman M, Lujan B, Yiu G, Association for Research in Vision and Ophthalmology 2016 Annual Meeting, 1/1/2017
• Macular Society Collaborative Retrospective Study of Ocriplasmin for Vitreomacular Traction
  Lim J, Glassman A, Aiello LP, Chakravarthy U, Flaxel C, Singerman L, Spaide R, Arroyo J, Bakri S, Barr C, Baumal C, Blinder K, Chaudry N, Chong V, Edwards A, Elman M, ..., Macula Society, 39th Annual Meeting, 1/1/2016
• Is there a Role for Flourescein Angiography in the Monitoring of eyes with Neovascular Age-Related Macular Degeneration receiving Anti-VEGF Therapy?
  Khurana RN, Hill L, Ghanekar A, Gune S, Retina Society, 49th Annual Scientific Meeting, 1/1/2016
• Association between prior response to ranibizumab treatment and disease quiescence: Implications for AMD dosing
  Khurana RN, Chang L, Shapiro H, Ghanekar A, Gune S, Association for Research in Vision and Ophthalmology 2016 Annual Meeting, 1/1/2016
• Secondary Ocular Hypertension after Dexamethasone Implant (Ozurdex) in the routine clinical practice
  Hemarat K, Kemmer J, Eaton A, Khurana RN, Stewart JM, Association for Research in Vision and Ophthalmology 2016 Annual Meeting, 1/1/2016
• Does Past Treatment Interval in a PRN Regimen Inform Future Patterns in Patients With Neovascular AMD Treated with Ranibizumab?
  Chang LK, Khurana RN, Shapiro H, Ghanekar AA, Gune S, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Sustained InTravitreal DexAmetHasone Implant for Uveitic Macular Edema: One Year Results from the TAHOE Study
  Khurana RN, Wieland MR, Palmer JD, Chang LK, Bansal AS, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• OCT Changes on Transition Back to Bevacizumab or Ranibizumab from Aflibercept in Recurrent Neovascular Age-related Macular Degeneration
  Slean GR, Stewart JM, Khurana RN, Hemarat K, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Increasing Sleep Duration is Associated With Geographic Atrophy and Age-Related Macular Degeneration
  Palmer JD, Boldrey EE, Wieland MR, Khurana RN, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Dexamethasone Intravitreal Implant for Pseudophakic Cystoid Macular Edema Following Cataract Surgery in Diabetic Patients
  Wieland MR, Palmer JD, Khurana RN, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• The Association of Epiretinal Membrane With Macular Hole Formation After Rhegmatogenous Retinal Detachment Repair
  Bansal AS, Khurana RN, Wykoff CC, Akiyama K, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Intravitreal Aflibercept for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions: 1 Year results from the NEWTON Study
  Khurana RN, Palmer JD, Wieland MR, Chang LK, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Secondary Ocular Hypertension and the Need for Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
  Stewart JM, Eaton AM, Hemarat K, Porco T, Khurana RN, Kemmer JD, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Progression of Epiretinal Membrane after receiving Dexamethasone Intravitreal Implant (Ozurdex)
  Hemarat K, Stewart JM, Khurana RN, Liu Q, Kemmer JD, Laovirojjanakul W, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• Clinical Outcomes of Patients Undergoing Surgery for Inflammatory Macular Holes
  Gonzalez M, Mandelcorn E, Khurana RN, Albini T, American Society of Retina Specialists 34nd Annual Meeting, 1/1/2016
• A Multicenter, Double Masked Phase 2 Clinical Trial evaluating Abicipar Pegol for Diabetic Macular Edema
  Hassan TS, Callahan DG, Khurana RN, Gupta S, Maturi RK, Li XY, Lopez FJ, Ker KJ, JiaoJ, Schneider S, American Academy of Ophthalmology, Retina Subspecialty Day, 1/1/2016
• Clinical Value of Prior Response to Anti-VEGF Treatment and Implications for AMD Dosing: A HARBOR Study Subanalysis
  Khurana RN, Chang LK, Shapiro H, Ghanekar A, Gune S, American Academy of Ophthalmology, 1/1/2016
• Association between Prior Response to Ranibizumab Treatment and Disease Quiescence: Implications for AMD dosing
  Khurana R, Association for Research in Vision and Ophthalmology Annual Meeting, Seattle, WA, 1/1/2016
• Is there a Role for Flourescein Angiography in the Monitoring of eyes with Neovascular Age-Related Macular Degeneration receiving Anti-VEGF Therapy?
  Khurana R, Retina Society 49th Annual Scientific Meeting, San Diego, CA, 1/1/2016
• Clinical Value of Prior Response to Anti-VEGF Treatment and Implications for AMD Dosing: A HARBOR Study Subanalysis
  Khurana R, American Academy of Ophthalmology Annual Meeting, Chicago, IL, 1/1/2016
• Intravitreal Aflibercept Injection for previously Treated Macular Edema associated with Central Retinal Vein Occlusion: Twelve-Month Results from the NEWTON Study
  Khurana R, American Academy of Ophthalmology Annual Meeting, Las Vegas, NV, 1/1/2015
• Join now to see all

Lectures

• Uveitis Controversies by the Bay 
  San Francisco, CA - 1/1/2016
• Uveitis, San Diego!! (It’s Kind of a Big Deal) 
  San Diego, CA - 1/1/2014
• Powerplay: Vitreoretinal Surgery in Inflamed Eyes 
  Toronto, ON - 1/1/2013
• Should We Relax or Contract the Outflow Pathway Cells to Lower IOP? Targeting the Kinases 
  Durham, NC - 1/1/2001
• Join now to see all

Other

• Retinal Optical Coherence Tomography 
  Khurana RN, Bhisitkul RB, Foster BS, AAO Focal Points, Clinical Modules for Ophthalmologists
  1/1/2014
• Vogt-Koyanagi-Harada Disease 
  Khurana RN, Rao NA, Ophthalmology International
  1/1/2006